Specifications TableTableSubject areaBiologyMore specific subject areaCell biology, Molecular biologyType of dataImage, graph, figureHow data was acquiredQuantitative PCR, Western blot, Transwell invasion assayData formatRawExperimental factorsCells were overexpressed with ERK5, DDIAS, β-catenin or transfected with siRNA against ERK1, ERK2, ERK5, MEF2B, DDIASExperimental featuresSamples were HeLa, non-small cell lung cancer cells, NCI-H1299, NCI-H1703 cellsData source locationDaejeon, South KoreaData accessibilityData is available with the article

**Value of the data**•Transcription of DDIAS is activated by ERK5/MEF2B pathway in lung cancer cells.•Increase of DDIAS transcription activates β-catenin signaling to promote lung cancer cell invasion.•The data provide evidence that DDIAS is a potential therapeutic target of lung cancer.

1. Data {#s0005}
=======

DDIAS is highly expressed in lung cancers and is involved in cisplatin resistance [@bib2], [@bib3]. In HeLa cells, genetic and pharmacological inhibition of MEK/ERK5 suppressed EGF-induced DDIAS transcription, whereas ERK5 overexpression increased DDIAS mRNA level ([Fig. 1](#f0005){ref-type="fig"}). DDIAS knockdown dramatically decreased β-catenin protein level in HeLa cells ([Fig. 2](#f0010){ref-type="fig"}). Consistent with data in HeLa cells, inhibition of ERK5 suppressed DDIAS transcription on EGF exposure in lung cancer cell lines ([Fig. 3](#f0015){ref-type="fig"}). In addition, MEF2B knockdown reduced EGF-induced DDIAS expression in lung cancer cells ([Fig. 4](#f0020){ref-type="fig"}). Furthermore, DDIAS knockdown inhibited β-catenin accumulation and lung cancer cell invasion ([Fig. 5](#f0025){ref-type="fig"}).

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Cell culture and transfection {#s0015}
----------------------------------

HeLa cells were cultured in Dulbecco׳s modified Eagle׳s medium and non-small cell lung cancer cell, NCI-H1703 and NCI-H1299 cells were cultured in RPMI-1640 containing 10% fetal bovine serum (FBS), 50 U/mL of penicillin, and 50 μg/mL of streptomycin (Invitrogen, Carlsbad, CA, USA) in an incubator at 37 °C and 5% CO~2~. Knockdown and overexpression of target genes experiment were performed as described [@bib1]. Cells were transiently transfected with HA-ERK5, HA-p300, Flag-DDIAS or HA-β-catenin using Turbofect (ThermoScientific, Rockford, IL) [@bib4].

2.2. RT-PCR {#s0020}
-----------

Total RNA extraction and Real-time PCR were performed as described [@bib1]. The cycling conditions were 95 °C for 15 min and 40 cycles of 95 °C for 15 s, 55 °C for 15 s and 72 °C for 15 s. All reactions were performed in triplicate and normalized to GAPDH as an internal control. The values are presented as the mean±S.E.M.

2.3. Co-immunoprecipitation assays {#s0025}
----------------------------------

Co-immunoprecipitation assay was performed as previously described [@bib5]. Cell lysates were immunoprecipitated with agarose-conjugated anti-HA antibody. Then, Western blot analyses were carried out using antibodies to peroxidase-conjugated anti-HA or anti-MEF2B antibodies.

2.4. Immunocytochemistry {#s0030}
------------------------

Immunocytochemistry analysis was performed as described [@bib1]. The fixed cells were incubated with anti-β-catenin antibody in 1% BSA solutions. Cells were then incubated with fluorescein-conjugated secondary antibodies (FITC, Santa Cruz). Finally, the cells were counterstained with DAPI to label nuclei and were then analyzed with a fluorescence microscope (LSM5 Live DuoScan, Zeiss).

2.5. Invasion assay {#s0035}
-------------------

Invasion assay was performed as described [@bib1]. Serum-starved cells (1×10^5^) were seeded in a Matrigel-coated chamber (BD Biosciences, Palo Alto, CA, USA) with 8.0-μm pores (Corning) with or without 100 ng/ml EGF. More than five views were analyzed under a light microscope. All experiments were performed twice in triplicate.
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![**Determination of DDIAS mRNA expression using real-time PCR in HeLa cells.** (A) ERK5 knockdown inhibited DDIAS mRNA expression. (B) MEK5 (BIX02189) or ERK5 (XMD8-92) inhibitors suppressed EGF-induced DDIAS mRNA expression. (C) Overexpression of HA-ERK5 increased EGF-induced DDIAS mRNA expression. Quantitative reverse transcription-PCR (qRT-PCR) was performed. \**P*\<0.05, \*\**P*\<0.01 vs. siScr/EGF, Con/EGF or Vec/EGF. (D) Overexpression of HA-ERK5 or Myc-MEF2B has no effect on EGF-induced NFAT promoter activity. Cells were transfected with HA-ERK5, Myc-MEF2B or HA-NFATc1 and NFAT-luciferase reporter construct (NFAT-Luc) together. \*\**P*\< 0.01 vs Vec/Con. NS, no significance. (E) p300 does not interact with MEF2B. HeLa cells were transfected with HA-p300 and treated with 100 ng/ml EGF for 3 h. Immunoprecipitation assays were performed using anti-HA and detected using an anti-MEF2B antibody.](gr1){#f0005}

![**DDIAS knockdown destabilizes β-catenin protein expression.** (A) β-catenin mRNA and protein expression. HeLa cells were transfected with siRNA against ERK5, DDIAS1 or DDIAS2 for 60 h. qRT-PCR and Western blotting analyses were performed. (B) The effect of DDIAS on β-catenin mRNA expression. (C) β-catenin staining in DDIAS knockdown cells. HeLa cells were transfected with 20 nM of DDIAS siRNA for 60 h. Immunocytochemistry was performed using an anti-β-catenin antibody. The cell nuclei were stained with DAPI. Scale bar, 20 μm. (D) The effect of Flag-DDIAS overexpression on β-catenin expression. (E) MMP1 or MMP3 expression following DDIAS knockdown. HeLa cells were treated with EGF for the indicated times, and qRT-PCR was performed. The values represent the mean±SEM of three independent experiments. \**P*\<0.05, \*\**P*\< 0.01 vs. siScr/EGF.](gr2){#f0010}

![**Inhibition of ERK5 suppresses DDIAS expression in lung cancer cells**. NCI-H1703 (H1703) and NCI-H1299 (H1299) cells were pretreated with XMD8-92 for 1 h and then incubated with 100 ng/ml of EGF for 12 h. qRT-PCR was performed. The values represent the mean±SEM of three independent experiments performed in triplicate. \**P*\<0.05 vs. EGF.](gr3){#f0015}

![**MEF2B knockdown suppresses EGF-induced DDIAS expression in lung cancer cells.** H1703 and H1299 cells were transfected with 40 nM of siScr or siMEF2B for 48 h and then incubated with 100 ng/ml of EGF for 12 h. qRT-PCR was performed. The values represent the mean±SEM of three independent experiments performed in triplicate. \**P*\<0.05 vs. EGF.](gr4){#f0020}

![β**-catenin protein expression following DDIAS knockdown**. (A) DDIAS knockdown suppresses EGF-induced β-catenin protein accumulation in NCI-H1703 and NCI-H1299 cells. Western blotting was performed using anti-β-catenin, anti-DDIAS or anti-GAPDH antibodies. (B) β-catenin overexpression restores the cell invasion repressed by DDIAS knockdown. NCI-H1299 cells were transfected with 20 nM of siScr or siDDIAS for 24 h and then transfected with vector control or HA-β-catenin for 24 h. The values represent the mean±SEM of two independent experiments performed in triplicate. \*\**P*\< 0.01 vs. siScr/EGF.](gr5){#f0025}
